Skip to main content
logo
Filana Therapeutics, Inc. (FLNA)
NASDAQ: FLNA · Real-Time Price · USD
0.6593
-0.0292 (-4.24%)
At close: Oct 21, 2026, 4:00 PM EDT
0.6724
+0.0131 (1.99%)
After-hours: Oct 21, 2026, 7:30 PM EDT

Filana Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-42.28-90.97-24.34-97.22-76.25-32.39
Depreciation & Amortization
0.990.941.131.531.30.53
Stock-Based Compensation
17.9219.5816.294.592.071.76
Other Operating Activities
---108.18---
Change in Accounts Payable
-3.5333.99-2.926.9-3.456.22
Change in Other Net Operating Assets
-1.794.211.092.18-1.19-6.32
Operating Cash Flow
-28.7-32.25-116.93-82.03-77.51-30.2
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-0.6-0.58-0.1-0.41-2.71-22.21
Investing Cash Flow
-0.6-0.58-0.1-0.41-2.71-22.21

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Issuance of Common Stock
-0.09124.472.5647.8192.34
Other Financing Activities
-0.4-0.33----
Financing Cash Flow
-0.4-0.24124.472.5647.8192.34

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
-29.7-33.077.44-79.88-32.42139.93

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-29.3-32.83-117.03-82.44-80.23-52.41
Free Cash Flow Growth
------
Free Cash Flow Per Share
-0.61-0.68-2.51-1.97-2.00-1.33
Levered Free Cash Flow
3.9820.22-79.18-51.63-54-40.39
Unlevered Free Cash Flow
3.9820.22-79.18-51.63-54-40.39

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Change in Working Capital
-5.3238.2-1.839.08-4.64-0.1
SEC Filings: 10-K · 10-Q